Counselors in Superior, NE Accepting Medicare
5 Counselors found. Showing 1 - 5
 Mrs. Peggy Ann Meyer, LCSW Counselor Medicare: Accepting Medicare Assignments Practice Location: 520 E 10th St, Superior, NE 68978 Phone: 402-879-4432 Fax: 402-879-3401 |
Mrs. Cindy Ann Betka, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 118 W 4th St, Superior, NE 68978 Phone: 402-879-5959 Fax: 402-879-3174 |
Mrs. Krista Marie Holeman, LIMHP, LADC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 520 E 10th St, Superior, NE 68978 Phone: 402-207-1542 |
Sharon Greenwood, LMHP CMFT LADC CPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 344 North Dakota, Superior, NE 68978 Phone: 402-879-4133 Fax: 402-879-4801 |
Casey Zoltenko Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 520 E 10th St, Superior, NE 68978 Phone: 402-207-1542 |
News Archive
Justices consider whether Medicaid expansion is constitutional or coercive
During the Supreme Court's last hour of a marthon series of oral arguments, some justices indicated strong disagreement with the challenge brought by 26 states to the health law's Medicaid expansion.
Promising Phase 2 data of perifosine in CLL and HL presented at 52nd ASH
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
Global tobacco giant conceals 30 year old research into the dangers of passive smoking
A public-health article published online by THE LANCET suggests that Philip Morris, one of the world's leading tobacco manufacturers, was covertly involved in scientific research into the health effects of tobacco 30 years ago, and conducted research into the dangers of passive smoking which do not appear to have been published.
Sanofi announces FDA approval of Toujeo insulin to improve glycemic control in people with diabetes
Sanofi announced today that the U.S. Food and Drug Administration approved Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal insulin, to improve glycemic control in adults living with type 1 and type 2 diabetes. Toujeo is expected to be available in the U.S. at the beginning of Q2 2015.
Improved primary care may help reduce hospital readmissions for diabetes patients
PEOPLE who regularly visit their family doctor following discharge for a diabetes-related hospitalisation significantly reduce their chance of being readmitted, an Australian study has found
› Verified 4 days ago